480 related articles for article (PubMed ID: 32790830)
1. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.
Yan F; Li H; Kaczmar JM; Sharma AK; Day TA; Neskey DM; Pipkorn P; Zenga J; Graboyes EM
JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1109-1119. PubMed ID: 32790830
[TBL] [Abstract][Full Text] [Related]
2. Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation.
Yan F; Li H; de Almeida JR; Kaczmar JM; Pipkorn P; Zenga J; Richardson MS; Neskey DM; Sharma AK; Day TA; Graboyes EM
Otolaryngol Head Neck Surg; 2021 Oct; 165(4):536-549. PubMed ID: 33618570
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
4. Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck.
Amit M; Liu C; Gleber-Netto FO; Kini S; Tam S; Benov A; Aashiq M; El-Naggar AK; Moreno AC; Rosenthal DI; Glisson BS; Ferrarotto R; Wong MK; Migden MR; Baruch EN; Li G; Khanna A; Goepfert RP; Nagarajan P; Weber RS; Myers JN; Gross ND
Cancer; 2021 Apr; 127(8):1238-1245. PubMed ID: 33320343
[TBL] [Abstract][Full Text] [Related]
5. The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate-risk HPV-negative HNSCC.
Tasoulas J; Lenze NR; Farquhar D; P Schrank T; Shen C; Shazib MA; Singer B; Patel S; Grilley Olson JE; Hayes DN; Gulley ML; Chera BS; Hackman T; Olshan AF; Weiss J; Sheth S
Cancer Med; 2021 May; 10(10):3231-3239. PubMed ID: 33934525
[TBL] [Abstract][Full Text] [Related]
6. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
Chen MM; Colevas AD; Megwalu U; Divi V
Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
[TBL] [Abstract][Full Text] [Related]
7. Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification.
Yoshida EJ; Luu M; David JM; Kim S; Mita A; Scher K; Shiao SL; Tighiouart M; Ho AS; Zumsteg ZS
Head Neck; 2018 Jun; 40(6):1228-1236. PubMed ID: 29417700
[TBL] [Abstract][Full Text] [Related]
8. Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiation.
Zumsteg ZS; Luu M; Kim S; Tighiouart M; Mita A; Scher KS; Lu DJ; Shiao SL; Mallen-St Clair J; Ho AS
Ann Oncol; 2019 Jan; 30(1):76-84. PubMed ID: 30395159
[TBL] [Abstract][Full Text] [Related]
9. Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment.
Cramer JD; Ferris RL; Kim S; Duvvuri U
Oral Oncol; 2018 Dec; 87():170-176. PubMed ID: 30527235
[TBL] [Abstract][Full Text] [Related]
10. Association of Core Biopsy With Extranodal Extension in Surgically Treated Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
Zhu VL; Rand DR; Arnold KE; Pagedar NA; Bayon R; Buchakjian MR
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):955-960. PubMed ID: 37433026
[TBL] [Abstract][Full Text] [Related]
11. Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).
Balk M; Rupp R; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Traxdorf M; Eckstein M; Speer S; Semrau S; Fietkau R; Iro H; Hecht M; Gostian AO
BMC Cancer; 2021 Nov; 21(1):1236. PubMed ID: 34794411
[TBL] [Abstract][Full Text] [Related]
12. Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis.
Kirke DN; Qureshi MM; Kamran SC; Ezzat W; Jalisi S; Salama A; Everett PC; Truong MT
Head Neck; 2018 Jun; 40(6):1174-1184. PubMed ID: 29417687
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
[TBL] [Abstract][Full Text] [Related]
14. Intratumor heterogeneity could inform the use and type of postoperative adjuvant therapy in patients with head and neck squamous cell carcinoma.
Mroz EA; Patel KB; Rocco JW
Cancer; 2020 Jan; 126(9):1895-1904. PubMed ID: 32083741
[TBL] [Abstract][Full Text] [Related]
15. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
16. The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database.
Gootee J; Patel M; Aurit S; Silberstein P
Clin Transl Oncol; 2020 Dec; 22(12):2264-2274. PubMed ID: 32440914
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes for head and neck cancer patients with N3 cervical nodal metastases.
Virk JS; Ingle M; Podesta CM; Gujral DM; Awad Z
Clin Otolaryngol; 2020 May; 45(3):342-349. PubMed ID: 31869000
[TBL] [Abstract][Full Text] [Related]
18. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy.
Iovoli AJ; Hermann GM; Ma SJ; Platek AJ; Farrugia MK; Yau E; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Singh AK
JAMA Netw Open; 2020 Jun; 3(6):e207199. PubMed ID: 32602907
[TBL] [Abstract][Full Text] [Related]
19. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
[TBL] [Abstract][Full Text] [Related]
20. Association of Surgical Margin Distance With Survival in Patients With Resected Head and Neck Squamous Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial.
Sunkara PR; Graff JT; Cramer JD
JAMA Otolaryngol Head Neck Surg; 2023 Apr; 149(4):317-326. PubMed ID: 36821132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]